D. Litvinchuk

RISK PREDICTION OF PORTAL HYPERTENSION IN PATIENTS WITH HCV-ASSOCIATED LIVER CIRRHOSIS

I. Karpov, D. Litvinchuk, D. Danilau, 2019, Hepatology and Gastroenterology.

Ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin for treatment of chronic hepatitis C 1 genotype in the Republic of Belarus

I. Karpov, D. Litvinchuk, D. Danilau, 2017, Clinical and experimental hepatology.

Association of TNF-α and CCL5 with response to interferon-based therapy in patients with HCV 1 genotype

I. Karpov, O. Krasko, D. Litvinchuk, 2017, Clinical and experimental hepatology.